step two, adding the solid phase resin, reacting for 24 hours at 80 in N-methylpyrrolidone, carrying out suction filtration, washing the solid phase resin with DCM, adding a DCM solvent of 25% TFA, and reacting for 2 hours at room temperature to obtain the 1- (2-hydroxyethyl) imidazole solid phase resin without tert-butyl protection or the 1- (3-hydroxypropyl) -1H-imidazole solid phase resin without tert-butyl protection
doi: 10.1038/nature04404 65 GerhardD
With more than 20 years of experience in public relations and brand storytelling, Tami specializes in translating industry trends into clear, actionable insights that support aspiring and ISSA-certified personal trainers, health coaches, and nutrition professionals in building successful wellness careers.
In the SURPASS clinical program (phase III development programs for T2D), doses of 5, 10, and 15 mg, which are attained following a stepwise dose escalation, are being studied
However, developing an effective, safe, and tolerable oral small-molecule GLP-1 has proven incredibly challenging
10.1016/j.molmet.2021.101351 16 DucaF
